soul and body

Hospitals accredited by the Society of Chest Pain Centers (SCPC) have been shown to perform better in the heart attack core measures established by Centers for Medicare and Medicaid Services (CMS) as compared to non-accredited hospitals, according to a national study led by an Emory University researcher.

The world’s largest cardiac surgery clinical trial, expected to involve 4,700 patients, will be undertaken by researchers at the Population Health Research Institute of Hamilton Health Sciences and McMaster University. The trial will investigate the differences in outcomes of using on-pump versus off-pump techniques during coronary artery bypass surgery, to document and compare short- and long-tem benefits of both. The CORONARY trial, lead by Drs.

Boehringer Ingelheim announced that a new formulation of its powerful blood pressure lowering drug, telmisartan (Micardis®) with hydrochlorothiazide (HCTZ), is now available in the UK. The fixed dose combination of 80mg telmisartan and 25mg HCTZ, which will be marketed as MicardisPlus® 80/25mg, is licensed for the treatment of essential hypertension in people whose blood pressure is not adequately controlled on 80mg telmisartan/12.